Microbiology and Immunology

You are here

Home > Publications > Publications

Publications

Found 526 results
Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is B  [Clear All Filters]
2010
Cheng Y-W, Idrees K, Shattock R, Khan SA, Zeng Z, Brennan CW, Paty P, Barany F.  2010.  Loss of imprinting and marked gene elevation are 2 forms of aberrant IGF2 expression in colorectal cancer.. Int J Cancer. 127(3):568-77.
Cheng Y-W, Idrees K, Shattock R, Khan SA, Zeng Z, Brennan CW, Paty P, Barany F.  2010.  Loss of imprinting and marked gene elevation are 2 forms of aberrant IGF2 expression in colorectal cancer.. Int J Cancer. 127(3):568-77.
Rajadhyaksha AM, Elemento O, Puffenberger EG, Schierberl KC, Xiang JZ, Putorti ML, Berciano J, Poulin C, Brais B, Michaelides M et al..  2010.  Mutations in FLVCR1 cause posterior column ataxia and retinitis pigmentosa.. Am J Hum Genet. 87(5):643-54.
Rajadhyaksha AM, Elemento O, Puffenberger EG, Schierberl KC, Xiang JZ, Putorti ML, Berciano J, Poulin C, Brais B, Michaelides M et al..  2010.  Mutations in FLVCR1 cause posterior column ataxia and retinitis pigmentosa.. Am J Hum Genet. 87(5):643-54.
Pingle M, Rundell M, Das S, Golightly LM, Barany F.  2010.  PCR/LDR/universal array platforms for the diagnosis of infectious disease.. Methods Mol Biol. 632:141-57.
Blumenthal A, Trujillo C, Ehrt S, Schnappinger D.  2010.  Simultaneous analysis of multiple Mycobacterium tuberculosis knockdown mutants in vitro and in vivo.. PLoS One. 5(12):e15667.
Bontjer I, Melchers M, Eggink D, David K, Moore JP, Berkhout B, Sanders RW.  2010.  Stabilized HIV-1 envelope glycoprotein trimers lacking the V1V2 domain, obtained by virus evolution.. J Biol Chem. 285(47):36456-70.
Bontjer I, Melchers M, Eggink D, David K, Moore JP, Berkhout B, Sanders RW.  2010.  Stabilized HIV-1 envelope glycoprotein trimers lacking the V1V2 domain, obtained by virus evolution.. J Biol Chem. 285(47):36456-70.
Biswas T, Small J, Vandal O, Odaira T, Deng H, Ehrt S, Tsodikov OV.  2010.  Structural insight into serine protease Rv3671c that Protects M. tuberculosis from oxidative and acidic stress.. Structure. 18(10):1353-63.
Lagal V, Binder EM, Huynh M-H, Kafsack BFC, Harris PK, Diez R, Chen D, Cole RN, Carruthers VB, Kim K.  2010.  Toxoplasma gondii protease TgSUB1 is required for cell surface processing of micronemal adhesive complexes and efficient adhesion of tachyzoites.. Cell Microbiol. 12(12):1792-808.
2009
Ingallinella P, Bianchi E, Ladwa NA, Wang Y-J, Hrin R, Veneziano M, Bonelli F, Ketas TJ, Moore JP, Miller MD et al..  2009.  Addition of a cholesterol group to an HIV-1 peptide fusion inhibitor dramatically increases its antiviral potency.. Proc Natl Acad Sci U S A. 106(14):5801-6.
Ingallinella P, Bianchi E, Ladwa NA, Wang Y-J, Hrin R, Veneziano M, Bonelli F, Ketas TJ, Moore JP, Miller MD et al..  2009.  Addition of a cholesterol group to an HIV-1 peptide fusion inhibitor dramatically increases its antiviral potency.. Proc Natl Acad Sci U S A. 106(14):5801-6.
Bacolod MD, Schemmann GS, Giardina SF, Paty P, Notterman DA, Barany F.  2009.  Emerging paradigms in cancer genetics: some important findings from high-density single nucleotide polymorphism array studies.. Cancer Res. 69(3):723-7.
Bacolod MD, Schemmann GS, Giardina SF, Paty P, Notterman DA, Barany F.  2009.  Emerging paradigms in cancer genetics: some important findings from high-density single nucleotide polymorphism array studies.. Cancer Res. 69(3):723-7.
Banerjee K, Andjelic S, Klasse PJohan, Kang Y, Sanders RW, Michael E, Durso RJ, Ketas TJ, Olson WC, Moore JP.  2009.  Enzymatic removal of mannose moieties can increase the immune response to HIV-1 gp120 in vivo.. Virology. 389(1-2):108-21.
Wang S, Haynes C, Barany F, Ott J.  2009.  Genome-wide autozygosity mapping in human populations.. Genet Epidemiol. 33(2):172-80.
Kafsack BFC, Pena JDO, Coppens I, Ravindran S, Boothroyd JC, Carruthers VB.  2009.  Rapid membrane disruption by a perforin-like protein facilitates parasite exit from host cells.. Science. 323(5913):530-3.
Blumenthal A, Kobayashi T, Pierini LM, Banaei N, Ernst JD, Miyake K, Ehrt S.  2009.  RP105 facilitates macrophage activation by Mycobacterium tuberculosis lipoproteins.. Cell Host Microbe. 5(1):35-46.
Blumenthal A, Kobayashi T, Pierini LM, Banaei N, Ernst JD, Miyake K, Ehrt S.  2009.  RP105 facilitates macrophage activation by Mycobacterium tuberculosis lipoproteins.. Cell Host Microbe. 5(1):35-46.
Barry CE, Boshoff HI, Dartois V, Dick T, Ehrt S, Flynn JA, Schnappinger D, Wilkinson RJ, Young D.  2009.  The spectrum of latent tuberculosis: rethinking the biology and intervention strategies.. Nat Rev Microbiol. 7(12):845-55.
Barry CE, Boshoff HI, Dartois V, Dick T, Ehrt S, Flynn JA, Schnappinger D, Wilkinson RJ, Young D.  2009.  The spectrum of latent tuberculosis: rethinking the biology and intervention strategies.. Nat Rev Microbiol. 7(12):845-55.
Kang YKenneth, Andjelic S, Binley JM, Crooks ET, Franti M, Iyer SPrasad N, Donovan GP, Dey AK, Zhu P, Roux KH et al..  2009.  Structural and immunogenicity studies of a cleaved, stabilized envelope trimer derived from subtype A HIV-1.. Vaccine. 27(37):5120-32.
Berro R, Sanders RW, Lu M, Klasse PJ, Moore JP.  2009.  Two HIV-1 variants resistant to small molecule CCR5 inhibitors differ in how they use CCR5 for entry.. PLoS Pathog. 5(8):e1000548.
Allred DR, Barbet AF, J Barry D, Deitsch KW.  2009.  varDB: common ground for a shifting landscape.. Trends Parasitol. 25(6):249-52.
Allred DR, Barbet AF, J Barry D, Deitsch KW.  2009.  varDB: common ground for a shifting landscape.. Trends Parasitol. 25(6):249-52.